These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 31307405

  • 1. Prognostic value of TGF-β in lung cancer: systematic review and meta-analysis.
    Li J, Shen C, Wang X, Lai Y, Zhou K, Li P, Liu L, Che G.
    BMC Cancer; 2019 Jul 15; 19(1):691. PubMed ID: 31307405
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of let-7 in lung cancer: systematic review and meta-analysis.
    Shen C, Li J, Che G.
    Transl Cancer Res; 2020 Oct 15; 9(10):6354-6361. PubMed ID: 35117243
    [Abstract] [Full Text] [Related]

  • 3. Clinicopathological and prognostic significance of Nestin expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.
    Li S, Lai Y, Fan J, Shen C, Che G.
    Clin Exp Med; 2017 May 15; 17(2):161-174. PubMed ID: 27099933
    [Abstract] [Full Text] [Related]

  • 4. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
    Li S, Wang Z, Huang J, Cheng S, Du H, Che G, Peng Y.
    BMC Cancer; 2016 Nov 11; 16(1):877. PubMed ID: 27835987
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of stromal decorin expression in patients with breast cancer: a meta-analysis.
    Li SJ, Chen DL, Zhang WB, Shen C, Che GW.
    J Thorac Dis; 2015 Nov 11; 7(11):1939-50. PubMed ID: 26716032
    [Abstract] [Full Text] [Related]

  • 6. Prognostic Impact of Tissue Inhibitor of Metalloproteinase-1 in Non- Small Cell Lung Cancer: Systematic Review and Meta-Analysis.
    Selvaraj G, Kaliamurthi S, Lin S, Gu K, Wei DQ.
    Curr Med Chem; 2019 Nov 11; 26(42):7694-7713. PubMed ID: 30182835
    [Abstract] [Full Text] [Related]

  • 7. Correlation between p-STAT3 overexpression and prognosis in lung cancer: A systematic review and meta-analysis.
    Tong M, Wang J, Jiang N, Pan H, Li D.
    PLoS One; 2017 Nov 11; 12(8):e0182282. PubMed ID: 28797050
    [Abstract] [Full Text] [Related]

  • 8. Clinicopathological and prognostic significance of thyroid transcription factor-1 expression in small cell lung cancer: A systemic review and meta-analysis.
    Wang Y, Wu Y, Li J, Li J, Che G.
    Pathol Res Pract; 2019 Dec 11; 215(12):152706. PubMed ID: 31704153
    [Abstract] [Full Text] [Related]

  • 9. Podoplanin is a useful prognostic marker and indicates better differentiation in lung squamous cell cancer patients? A systematic review and meta-analysis.
    Hu L, Zhang P, Mei Q, Sun W, Zhou L, Yin T.
    BMC Cancer; 2020 May 14; 20(1):424. PubMed ID: 32408907
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with non-small cell lung cancer receiving immune checkpoint inhibitors: a meta-analysis.
    Yang T, Hao L, Yang X, Luo C, Wang G, Lin Cai C, Qi S, Li Z.
    BMJ Open; 2021 Sep 02; 11(9):e049123. PubMed ID: 34475167
    [Abstract] [Full Text] [Related]

  • 11. The prognostic value of miR-21 and miR-155 in non-small-cell lung cancer: a meta-analysis.
    Wang Y, Li J, Tong L, Zhang J, Zhai A, Xu K, Wei L, Chu M.
    Jpn J Clin Oncol; 2013 Aug 02; 43(8):813-20. PubMed ID: 23817461
    [Abstract] [Full Text] [Related]

  • 12. Prognostic impact of elevation of vascular endothelial growth factor family expression in patients with non-small cell lung cancer: an updated meta-analysis.
    Zheng CL, Qiu C, Shen MX, Qu X, Zhang TH, Zhang JH, Du JJ.
    Asian Pac J Cancer Prev; 2015 Aug 02; 16(5):1881-95. PubMed ID: 25773840
    [Abstract] [Full Text] [Related]

  • 13. Clinical Significance of HMGB-1 and TGF-β Level in Serum and BALF of Advanced Non-Small Cell Lung Cancer.
    Jakubowska K, Naumnik W, Niklińska W, Chyczewska E.
    Adv Exp Med Biol; 2015 Aug 02; 852():49-58. PubMed ID: 25753556
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.
    Zhu L, Yu H, Liu SY, Xiao XS, Dong WH, Chen YN, Xu W, Zhu T.
    PLoS One; 2015 Aug 02; 10(4):e0124230. PubMed ID: 25905787
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic role of B7-H4 in patients with non-small cell lung cancer: A meta-analysis.
    Tan Z, Shen W.
    Oncotarget; 2017 Apr 18; 8(16):27137-27144. PubMed ID: 28404927
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prognostic value of CD44 expression in non-small cell lung cancer: a systematic review.
    Luo Z, Wu RR, Lv L, Li P, Zhang LY, Hao QL, Li W.
    Int J Clin Exp Pathol; 2014 Apr 18; 7(7):3632-46. PubMed ID: 25120740
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.